A1 Refereed original research article in a scientific journal

Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth




AuthorsOlotu, Opeyemi; Koskenniemi, Anna-Riina; Ma, Lin; Paramonov, Valeriy; Laasanen, Sini; Louramo, Elina; Bourgery, Matthieu; Lehtiniemi, Tiina; Laasanen, Samuli; Rivero-Müller, Adolfo; Löyttyniemi, Eliisa; Sahlgren, Cecilia; Westermarck, Jukka; Ventelä, Sami; Visakorpi, Tapio; Poutanen, Matti; Vainio, Paula; Mäkelä, Juho-Antti; Kotaja, Noora

PublisherCell Reports

Publication year2024

JournalCell Reports

Article number114430

Volume43

Issue7

eISSN2211-1247

DOIhttps://doi.org/10.1016/j.celrep.2024.114430(external)

Web address https://www.cell.com/cell-reports/fulltext/S2211-1247(24)00759-9(external)

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/457106509(external)


Abstract

Cancer cells undergo major epigenetic alterations and transcriptomic changes, including ectopic expression of tissue- and cell-type-specific genes. Here, we show that the germline-specific RNA helicase DDX4 forms germ-granule-like cytoplasmic ribonucleoprotein granules in various human tumors but not in cultured cancer cells. These cancerous DDX4 complexes contain RNA-binding proteins and splicing regulators, including many known germ granule components. The deletion of DDX4 in cancer cells induces transcriptomic changes and affects the alternative splicing landscape of a number of genes involved in cancer growth and invasiveness, leading to the compromised capability of DDX4-null cancer cells to form xenograft tumors in immunocompromised mice. Importantly, the occurrence of DDX4 granules is associated with poor survival in patients with head and neck squamous cell carcinoma and a higher histological grade of prostate cancer. Taken together, these results show that the germ-granule-resembling cancerous DDX4 granules control gene expression and promote the malignant and invasive properties of cancer cells.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
This work was supported by the Academy of Finland, the Turku doctoral program of molecular medicine, the Sigrid Jusélius Foundation, the Novo Nordisk Foundation, the Jane and Aatos Erkko Foundation, and the Jalmari and Rauha Ahokas Foundation.


Last updated on 2025-31-03 at 14:32